Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2

Manuel González-Ortiz; María Guadalupe Castro-Martínez; Carolina Solís-Herrera; Elvira Graciela Alexanderson-Rosas; Eduardo Márquez-Rodríguez; Ángel Alfonso Garduño-Pérez; Alfredo Israel Servin-Caamaño; Manuel Duarte-Vega; Esperanza Martínez-Abundis; Enrique Cuitláhuac Morales-Villegas; Rafael Margarito Violante-Ortiz

doi:10.24245/mim.v37i5.4597

Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2

Translated title of the contribution: Pioglitazone, an effective alternative still valid for the control of type 2 diabetes

Manuel González-Ortiz
, María Guadalupe Castro-Martínez
, Carolina Solís-Herrera
, Elvira Graciela Alexanderson-Rosas
, Eduardo Márquez-Rodríguez
, Ángel Alfonso Garduño-Pérez
, Alfredo Israel Servin-Caamaño
, Manuel Duarte-Vega
, Esperanza Martínez-Abundis
, Enrique Cuitláhuac Morales-Villegas
, Rafael Margarito Violante-Ortiz

Research output: Contribution to journal › Article › peer-review

Abstract

This manuscript consists of a compacted review of pioglitazone, a thiazolidinedione which over the years has showed multiple beneficial effects in the treatment of type 2 diabetes that go beyond glycemic control and whose description intends to give to this glitazone the fair value that it has at the present time within the therapeutic arsenal and international recommendations for the management of patients with this disease.

Translated title of the contribution	Pioglitazone, an effective alternative still valid for the control of type 2 diabetes
Original language	Spanish
Pages (from-to)	800-812
Number of pages	13
Journal	Medicina Interna de Mexico
Volume	37
Issue number	5
DOIs	https://doi.org/10.24245/mim.v37i5.4597
State	Published - Sep 2021

Keywords

Glitazone
Pioglitazone
Thiazolidinedione
Type 2 diabetes

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.24245/mim.v37i5.4597

Cite this

González-Ortiz, M., Castro-Martínez, M. G., Solís-Herrera, C., Alexanderson-Rosas, E. G., Márquez-Rodríguez, E., Garduño-Pérez, Á. A., Servin-Caamaño, A. I., Duarte-Vega, M., Martínez-Abundis, E., Morales-Villegas, E. C., & Violante-Ortiz, R. M. (2021). Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2. Medicina Interna de Mexico, 37(5), 800-812. https://doi.org/10.24245/mim.v37i5.4597

González-Ortiz, M, Castro-Martínez, MG, Solís-Herrera, C, Alexanderson-Rosas, EG, Márquez-Rodríguez, E, Garduño-Pérez, ÁA, Servin-Caamaño, AI, Duarte-Vega, M, Martínez-Abundis, E, Morales-Villegas, EC & Violante-Ortiz, RM 2021, 'Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2', Medicina Interna de Mexico, vol. 37, no. 5, pp. 800-812. https://doi.org/10.24245/mim.v37i5.4597

@article{a7f2ea9bc35e401290ad9054d2332c4e,

title = "Pioglitazona, una alternativa efectiva a{\'u}n vigente para el control de la diabetes tipo 2",

abstract = "This manuscript consists of a compacted review of pioglitazone, a thiazolidinedione which over the years has showed multiple beneficial effects in the treatment of type 2 diabetes that go beyond glycemic control and whose description intends to give to this glitazone the fair value that it has at the present time within the therapeutic arsenal and international recommendations for the management of patients with this disease.",

keywords = "Glitazone, Pioglitazone, Thiazolidinedione, Type 2 diabetes",

author = "Manuel Gonz{\'a}lez-Ortiz and Castro-Mart{\'i}nez, \{Mar{\'i}a Guadalupe\} and Carolina Sol{\'i}s-Herrera and Alexanderson-Rosas, \{Elvira Graciela\} and Eduardo M{\'a}rquez-Rodr{\'i}guez and Gardu{\~n}o-P{\'e}rez, \{{\'A}ngel Alfonso\} and Servin-Caama{\~n}o, \{Alfredo Israel\} and Manuel Duarte-Vega and Esperanza Mart{\'i}nez-Abundis and Morales-Villegas, \{Enrique Cuitl{\'a}huac\} and Violante-Ortiz, \{Rafael Margarito\}",

year = "2021",

month = sep,

doi = "10.24245/mim.v37i5.4597",

language = "Spanish",

volume = "37",

pages = "800--812",

journal = "Medicina Interna de Mexico",

issn = "0186-4866",

publisher = "Comunicaciones Cientificas Mexicanas S.A. de C.V.",

number = "5",

}

TY - JOUR

T1 - Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2

AU - González-Ortiz, Manuel

AU - Castro-Martínez, María Guadalupe

AU - Solís-Herrera, Carolina

AU - Alexanderson-Rosas, Elvira Graciela

AU - Márquez-Rodríguez, Eduardo

AU - Garduño-Pérez, Ángel Alfonso

AU - Servin-Caamaño, Alfredo Israel

AU - Duarte-Vega, Manuel

AU - Martínez-Abundis, Esperanza

AU - Morales-Villegas, Enrique Cuitláhuac

AU - Violante-Ortiz, Rafael Margarito

PY - 2021/9

Y1 - 2021/9

N2 - This manuscript consists of a compacted review of pioglitazone, a thiazolidinedione which over the years has showed multiple beneficial effects in the treatment of type 2 diabetes that go beyond glycemic control and whose description intends to give to this glitazone the fair value that it has at the present time within the therapeutic arsenal and international recommendations for the management of patients with this disease.

AB - This manuscript consists of a compacted review of pioglitazone, a thiazolidinedione which over the years has showed multiple beneficial effects in the treatment of type 2 diabetes that go beyond glycemic control and whose description intends to give to this glitazone the fair value that it has at the present time within the therapeutic arsenal and international recommendations for the management of patients with this disease.

KW - Glitazone

KW - Pioglitazone

KW - Thiazolidinedione

KW - Type 2 diabetes

UR - https://www.scopus.com/pages/publications/85118536953

UR - https://www.scopus.com/pages/publications/85118536953#tab=citedBy

U2 - 10.24245/mim.v37i5.4597

DO - 10.24245/mim.v37i5.4597

M3 - Article

AN - SCOPUS:85118536953

SN - 0186-4866

VL - 37

SP - 800

EP - 812

JO - Medicina Interna de Mexico

JF - Medicina Interna de Mexico

IS - 5

ER -

Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this